Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Meeting ReportCardiovascular disease

Benefits of empagliflozin in Hispanics and non-Hispanics with heart failure: a sub analysis of the EMPEROR trials

Maria Gamero and Ileana Piña
The Annals of Family Medicine November 2023, 21 (Supplement 3) 4682; DOI: https://doi.org/10.1370/afm.22.s1.4682
Maria Gamero
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ileana Piña
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 21 no. Supplement 3 4682
DOI 
https://doi.org/10.1370/afm.22.s1.4682

Published By 
The Annals of Family Medicine
Print ISSN 
1544-1709
Online ISSN 
1544-1717
History 
  • Published online November 16, 2023.

Copyright & Usage 
© 2023 Annals of Family Medicine, Inc.

Statistics from Altmetric.com

Article usage

Article usage: November 2023 to April 2025

AbstractFullPdf
Nov 20232106
Dec 20232103
Jan 20242202
Feb 20241301
Mar 20241004
Apr 2024604
May 2024700
Jun 20241202
Jul 2024203
Aug 2024401
Sep 2024600
Oct 2024400
Nov 2024400
Dec 2024503
Jan 2025401
Feb 2025101
Mar 2025505
Apr 2025107
Previous
Back to top

In this issue

The Annals of Family Medicine: 21 (Supplement 3)
The Annals of Family Medicine: 21 (Supplement 3)
Vol. 21, Issue Supplement 3
1 Nov 2023
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Benefits of empagliflozin in Hispanics and non-Hispanics with heart failure: a sub analysis of the EMPEROR trials
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Benefits of empagliflozin in Hispanics and non-Hispanics with heart failure: a sub analysis of the EMPEROR trials
Maria Gamero, Ileana Piña
The Annals of Family Medicine Nov 2023, 21 (Supplement 3) 4682; DOI: 10.1370/afm.22.s1.4682

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Benefits of empagliflozin in Hispanics and non-Hispanics with heart failure: a sub analysis of the EMPEROR trials
Maria Gamero, Ileana Piña
The Annals of Family Medicine Nov 2023, 21 (Supplement 3) 4682; DOI: 10.1370/afm.22.s1.4682
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Creative Dissemination: Community-Engaged Mural to Disseminate the PORTRAIT Registry on Peripheral Arterial Disease
  • SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes
  • Intervention Strategies for Management of Comorbid Depression Among Individuals With Hypertension: A Scoping Review
Show more Cardiovascular disease

Similar Articles

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine